HARVEY CAPITAL MANAGEMENT INC - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 205 filers reported holding NPS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.

Quarter-by-quarter ownership
HARVEY CAPITAL MANAGEMENT INC ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$15,433,000
+37.6%
431,475
-0.0%
5.92%
+34.5%
Q3 2014$11,219,000
-21.3%
431,525
+0.0%
4.40%
-13.7%
Q2 2014$14,255,000
+12.3%
431,325
+1.7%
5.10%
+0.8%
Q1 2014$12,695,000
-23.9%
424,175
-22.8%
5.06%
-26.5%
Q4 2013$16,680,000
+0.2%
549,425
+5.0%
6.89%
-18.5%
Q3 2013$16,642,000
+4.1%
523,200
-50.5%
8.45%
+70.4%
Q2 2013$15,982,0001,057,8004.96%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 424,175$12,695,0005.06%
Opaleye Management Inc. 150,000$4,490,0003.32%
OAK RIDGE INVESTMENTS LLC 2,795,331$83,664,0002.10%
SCHOLTZ & COMPANY, LLC 60,350$1,806,0001.94%
SECTORAL ASSET MANAGEMENT INC 1,408,729$42,163,0001.73%
First Light Asset Management, LLC 79,099$2,367,0001.68%
FCG ADVISORS, LLC 71,146$2,129,0001.51%
Rhenman & Partners Asset Management AB 166,970$4,997,0001.50%
BENDER ROBERT & ASSOCIATES 73,611$2,203,0001.48%
Eventide Asset Management 283,900$8,497,0001.32%
View complete list of NPS PHARMACEUTICALS INC shareholders